06/16/2026
IN THE NEWS: Cooper University Health Care is among the first health systems in the United States to adopt the next-generation SEISMIQ™ Intravascular Lithotripsy System, an advanced intravascular lithotripsy technology that uses acoustic pressure waves to break up calcifications in the peripheral arteries and enhance vessel preparation prior to endovascular intervention.
Philip Batista, MD, a vascular surgeon and division head of vascular surgery at Cooper, recently performed Cooper’s first case using the SEISMIQ system, using the technology to treat a patient with complex peripheral arterial disease.
The SEISMIQ system is designed to help physicians more easily guide catheters through blood vessels, treat blocked or hardened areas with greater precision, and maintain better control during complex vascular procedures. For patients, this may translate into safer, more precise procedures with improved outcomes and expanded access to minimally invasive treatment options.
“Technologies like SEISMIQ are helping us treat patients with hard-to-reach or hardened blood vessels in a less invasive way,” said Dr. Batista, who also serves as associate professor of surgery at Cooper Medical School of Rowan University. “This system helps us prepare blood vessels more accurately before treatment and gives us another option for patients who may have had fewer choices in the past. Being among the first to use this technology at Cooper reflects our commitment to bringing advanced care to our patients.”
Cooper University Health Care’s vascular and endovascular surgery program provides comprehensive care for patients with complex blood vessel disorders, including aortic disease, carotid artery disease, and peripheral arterial and venous conditions. The program combines both minimally invasive endovascular techniques and traditional open surgical approaches to deliver individualized treatment based on each patient’s condition and needs.
As an academic health system and regional referral center, Cooper offers advanced procedural capabilities, including a hybrid operating room environment and participation in national and international clinical research trials. This integration of clinical care and research enables the team to treat a high volume of complex cases while advancing new technologies and therapies in vascular surgery.
